“MariMed Inc. (MRMD), a multi-state cannabis operator focused on branded consumer packaged goods and retail, is scheduled to report its fourth quarter and full-year 2025 results imminently. Wall Street consensus points to revenue around $40.6 million to $40.8 million for the quarter, with a per-share loss of $0.01. Full-year figures are projected at approximately $161 … Read more
“Ascend Wellness Holdings is poised to report its Q4 2025 results on March 12, 2026, with preliminary guidance pointing to approximately $120 million in net revenue and $30 million in Adjusted EBITDA, reflecting a 25% margin amid ongoing industry pressures. Despite a sequential revenue dip from Q3’s $124.7 million and a year-over-year decline, the company … Read more
Becton Dickinson (BD) is strategically rolling out innovative products in medication management, surgical safety, vascular access, and connected care solutions, reinforcing its position as a pure-play MedTech leader with over 90% recurring revenue. Recent launches like the Surgiphor™ 1000mL wound irrigation system, next-generation BD Pyxis™ Pro dispensing solution with AI-enabled BD Incada™ platform, and expansions … Read more
C.H. Robinson is aggressively advancing its Lean AI and Agentic Supply Chain platform, deploying over 30 AI agents to automate millions of logistics tasks, optimize operations, and deliver real-time decision-making for shippers and carriers. This innovation positions the company as a leader in transforming global supply chains through intelligent, adaptive technology. However, a major U.S. … Read more
Lufthansa Group reported a strong 2025 performance with adjusted operating profit reaching approximately €2 billion, surpassing expectations through disciplined cost management, fleet modernization, and robust passenger demand. Despite this, the escalating war involving Iran introduces significant geopolitical uncertainty, including airspace closures, flight reroutings, and surging oil prices. The company projects around 4% capacity growth for … Read more
Boliden released its comprehensive Annual and Sustainability Report for 2025, showcasing robust financial performance driven by elevated metal prices, strategic acquisitions expanding zinc and copper output, and continued progress in sustainability initiatives. Key highlights include strong operating profits, positive resource and reserve developments extending mine lives, and advancements in responsible production, climate action, and community … Read more
“In a significant policy shift driven by European Court of Justice directives, Malta ended its longstanding citizenship-by-direct-investment pathway in April 2025, replacing it with a merit-based naturalization system that emphasizes genuine contributions, exceptional achievements, and alignment with national interests. Immigrant Invest has provided detailed clarification on the reformed framework, highlighting remaining residency options like the … Read more
Cantor Fitzgerald has increased its price target on Cullen/Frost Bankers Inc. (NYSE: CFR) to $152 from $141 while maintaining a Neutral rating. This adjustment reflects growing confidence in the company’s strong fundamentals, Texas-centric growth, and ability to navigate the current interest rate environment effectively. The move comes as CFR shares trade around $140, with the … Read more
“In a landmark moment for family-building accessibility, The Surrogacy Foundation announces the arrival of baby girl McGill, the inaugural child born with support from its flagship $100,000 grant. Awarded to Georgia couple Shannon and Patrick McGill in late 2024, the funding helped overcome barriers after a traumatic prior delivery, turning a dream of expanding their … Read more
Zura Bio Limited (Nasdaq: ZURA), a clinical-stage biotech firm advancing innovative therapies for autoimmune and inflammatory diseases, has announced that its management team will engage with investors at two major conferences in Miami next week. The schedule includes a fireside chat at the Leerink Global Healthcare Conference on March 10, 2026, followed by one-on-one meetings … Read more